Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
NAT6 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
gl O-GlcNAc
ga O-GalNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
NAT6 Seems to be involved in N-acetylation. Acts on peptides with a N-terminal Met followed by Asp/Glu/Asn. May act as a tumor suppressor. Belongs to the acetyltransferase family. 2 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Secondary Metabolites Metabolism - limonene and pinene degradation; Acetyltransferase; Lipid Metabolism - glycerophospholipid; Amino Acid Metabolism - tyrosine; Amino Acid Metabolism - phenylalanine; EC 2.3.1.-
Cellular Component: mitochondrion; cytoplasm
Molecular Function: N-acetyltransferase activity
Reference #:  Q93015 (UniProtKB)
Alt. Names/Synonyms: FUS-2; FUS2; N-acetyltransferase 6; N-acetyltransferase 6 (GCN5-related); NAT6; Protein fus-2; Protein fusion-2; putative tumor suppressor
Gene Symbols: NAT6
Molecular weight: 31,445 Da
Basal Isoelectric point: 7.75  Predict pI for various phosphorylation states
Select Structure to View Below

NAT6

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  ENZYME  |  DISEASE  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

► Hide Isoforms
 
0 1 - gap
0 1 S8 MELILSTSPAELTLD
0 1 - gap
0 2 P205 VFTSRRLPATLLNAF
0 6 S217-p NAFPTAPsPRPPRKA
0 4 Y271-p KSLLETQyQNVRGRP
0 1 R275 ETQyQNVRGRPIFWM
  NAT6 iso2  
T14-p SPGPAKLtPTLDPTH
S30 MELILSTSPAELTLD
- gap
P227 VFTSRRLPATLLNAF
S239 NAFPTAPSPRPPRKA
Y293 KSLLETQYQNVRGRP
R297 ETQYQNVRGRPIFWM
  mouse

 
- gap
S8-p MELILSTsPAKLTLD
S44-p RQPELSLsPRLAELT
S233-p AFTNRRLsTTVLRAF
C245 RAFSKPPCPQPPCKE
Y299 QSPLETCYRDLkGCP
K303-a ETCYRDLkGCPIFWM
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.